Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches

American Journal of Transplantation

Volumn 11, Issue 4, 2011, Pages 719-724

  Cecka, J M ^a   Kucheryavaya, A Y ^b   Reinsmoen, N L ^c   Leffell, M S ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crossmatching; highly sensitized; histocompatibility; HLA antibodies; kidney allocation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ARTICLE; BLOOD GROUP TYPING; CALCULATED PANEL REACTIVE ANTIBODY; DONOR SELECTION; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; WAITING LISTS;

EID: 79953242302     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03340.x     Document Type: Article

References (9)

1. Cecka JM,. Calculated PRA (CPRA): The new measure of sensitization for transplant candidates. Am J Transplantation 2010; 10: 26-29.
2. Bray RA, Nolen JD, Larsen C, et al,. Transplanting the highly sensitized patient: The Emory algorithm. Am J Transplant 2006; 6: 2307-2315. (Pubitemid 44359415)
3. Appel JZ III, Hartwig MG, Cantu E III, Palmer SM, Reinsmoen NL, Davis RD,. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. Transplantation 2006; 81: 1049-1057. (Pubitemid 43670440)
4. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K,. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006; 82: 1524-1528. (Pubitemid 44967637)
5. Zangwill S, Ellis T, Stendahl G, Zahn A, Berger S, Tweddell J,. Practical application of the virtual crossmatch. Pediatr Transplant 2007; 11: 650-654. (Pubitemid 47174397)
6. Tambur AR, Leventhal J, Kaufman DB, Friedewald J, Miller J, Abecassis MM,. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: The Northwestern University experience. Transplantation 2008; 86: 1864-1868.
7. Zachary AA, Montgomery RA, Leffell MS,. Defining unacceptable antigens. Cur Opin Organ Transplant 2008; 13: 405-410.
8. Leffell MS, Cherikh WS, Laud GA, Zachary AA,. Improved definition of HLA frequencies among minorities and applicability to estimates of transplant compatibility. Transplantation 2007; 83: 964-972. (Pubitemid 46682739)
9. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F,. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008; 86: 1864-1868.